Table 1.
Baseline Demographics and Clinical Characteristics of the 128 Patients
Variable | Value |
---|---|
Center, No. (%) | |
Columbia University Medical Center | 18 (14.1) |
UCLA | 9 (7.0) |
Washington University in St Louis | 18 (14.1) |
Massachusetts General Hospital | 27 (21.1) |
University of Arkansas for Medical Sciences | 16 (12.5) |
Cleveland Clinic Foundation | 9 (7.0) |
Hospital of the University of Pennsylvania | 5 (3.9) |
University of Oklahoma | 4 (3.1) |
Tulane University | 16 (12.5) |
The University of Alabama at Birmingham | 6 (4.7) |
Age, median (range), y | 74 (23–99) |
Male sex, No. (%) | 65 (50.8) |
Race/ethnicity, No. (%) | |
White | 81 (63.2) |
African American | 38 (29.7) |
Hispanic | 7 (5.5) |
Other | 2 (1.6) |
Hypertension, No. (%) | 106 (82.8) |
Diabetes mellitus, No. (%) | 38 (29.7) |
Hyperlipidemia, No. (%) | 68 (53.3) |
Prior stroke, No. (%) | 39 (30.5) |
NIHSS score, median (range) | 15 (0–33) |
ASPECTS score, median (range) | 10 (5–10) |
Neurointerventional procedure, No. (%) | 18 (14.1) |
Stroke subtype, No. (%) | |
Small-vessel disease | 5 (4.1) |
Large-vessel disease | 11 (9.0) |
Cardioembolic | 57 (46.7) |
Cryptogenic | 13 (10.7) |
Other | 12 (9.8) |
Hematoma volume, median (range), mL | 25 (1–245) |
Time from initiation of rtPA therapy to sICH diagnosis, median (range), min | 470 (30–2572) |
Time from sICH diagnosis to treatment of sICH, median (range), min | 112 (12–628) |
Type of treatment, No. (%) | |
Any treatment | 49 (38.2) |
Fresh frozen plasma | 26 (20.3) |
Vitamin K | 7 (5.5) |
Cryoprecipitate | 40 (31.3) |
Platelet transfusion | 37 (28.9) |
Aminocaproic acid | 2 (1.6) |
Prothrombin complex concentrate | 3 (2.3) |
Recombinant factor VIIa | 3 (2.3) |
Surgical decompressive craniotomy or hematoma evacuation | 18 (14.6) |
Code status change to comfort measures in the first 24 h, No. (%) | 37 (28.9) |
Hematoma expansion after diagnosis, No. (%) | 22 (26.8) |
In-hospital mortality, No. (%) | 67 (52.3) |
Abbreviations: ASPECTS, Alberta Stroke Program Early CT [Computed Tomographic] Score; NIHSS, National Institutes of Health Stroke Scale; rtPA, recombinant tissue plasminogen activator; sICH, symptomatic intracerebral hemorrhage; UCLA, University of California, Los Angeles.